| Literature DB >> 17683947 |
Vera Rebmann1, Holger Nückel, Ulrich Dührsen, Hans Grosse-Wilde.
Abstract
HLA-G appears to be involved in regulatory functions counteracting the cellular immune response of T and NK cells by several pathways. We here summarize the HLA-G expression patterns in leukaemia with emphasis on the clinical relevance of this expression for disease progression. Especially in patients with B-chronic lymphocytic leukaemia (B-CLL) the HLA-G expression on B-CLL cells was strongly associated with a reduced treatment-free survival. The corresponding immunological parameters point to a broad immunosuppression in these patients. Thus, HLA-G seems to contribute to the impaired immune response in B-CLL supporting disease progression.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17683947 DOI: 10.1016/j.semcancer.2007.06.011
Source DB: PubMed Journal: Semin Cancer Biol ISSN: 1044-579X Impact factor: 15.707